Compass Pathways plc (Nasdaq: CMPS) announced that Co-founder and Chief Innovation Officer Dr. Ekaterina Malievskaia will step down from her executive...
The Daily Hit is a recap of the top financial news stories for May 30, 2023. On The Site Two Dozen Publicly Traded U.S. Cannabis Companies...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical–stage natural psychedelic drug development company, today announced interim...
Shares of NUMI jumped more than 30% on the news Tuesday morning. The post Numinus Wellness Shares Soar as Landmark Clinical Study of Psilocybin Therapy...
Bob Lee Murder handout from CASH App VIA PR NEWSWIRE – CASH App/Handout When Bob Lee, a 43-year-old technology executive, was stabbed to death in the...
Discover the psychedelic wonders of the Golden Teachers mushroom in our detailed guide. Learn about their potency and dosage and how to identify them in...
Reports Insights analyzes that the panic disorder market is growing with a CAGR of 4.3% during the forecast period (2023-2030), and the market is projected...
It can be tough (especially for Americans, what with the state of private health insurance) to know when to go to the doctor for a health...
By: Josh Sens May 26, 2023 Harboring yard-care woes? Don’t get angry, get educated! getty images Water covers nearly three-quarters of the planet, but...
The psychedelic substances 5-MeO-DMT causes a long-lasting increase in the number of tiny protrusions called dendritic spines in the brain, according to...
Small Pharma announces significant developments In Intellectual Property Portfolio The post Small Pharma Expands Intellectual Property Portfolio appeared...
Irwin Naturals Inc. (CSE: IWIN / OTC: IWINF / FRA: 97X) today reported its financial results for the fourth quarter and year ended December 31, 2022,...
Enveric Biosciences, Inc. (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD / NEO: MMED) today announced that it has released an investor presentation in connection with its 2023 Annual...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain...